Literature DB >> 22364548

The prevalence of type 2 idiopathic macular telangiectasia in two African populations.

Ferenc B Sallo1, Irene Leung, Wanjiku Mathenge, Fatima Kyari, Hannah Kuper, Clare E Gilbert, Alan C Bird, Tunde Peto.   

Abstract

PURPOSE: Type 2 idiopathic macular telangiectasia (MacTel) is a progressive retinal disease associated with a slow deterioration of visual acuity, starting in the fifth to seventh decades of life. The etiology and pathogenesis of the disease are little known, and no effective therapy is available. We aimed to estimate the prevalence and describe the phenotype of type 2 MacTel in two African populations.
METHODS: From two population-based cross-sectional surveys conducted nationally in Nigeria and in the Nakuru district of Kenya, patients with fundus features of type 2 MacTel were selected. Diagnosis was based on color fundus images, grading performed according to the MacTel Study protocol and staged using the Gass and Blodi system. Disease phenotype and clinical characteristics of affected participants were assessed.
RESULTS: Of 8599 total participants, five showed a phenotype compatible with type 2 MacTel. Prevalence was estimated as 0.06% (95% confidence interval [CI] 0.02-0.21%) in Kenya, 0.06% (95% CI 0.01-0.17%) in Nigeria, and overall at 0.06% (95% CI 0.02-0.14%). Mean age was 62 years (SD 5 years), four of five affected participants were female, and none had a history of diabetes. Median corrected visual acuity was 6/12 in the better eye and 6/69 in the worse eye.
CONCLUSIONS: The estimated prevalence and phenotype of type 2 MacTel in the African populations examined were similar to those in predominantly white populations. All data published so far are based on the analysis of color fundus images only and are thus likely to underestimate the true prevalence of this disease.

Entities:  

Mesh:

Year:  2012        PMID: 22364548     DOI: 10.3109/09286586.2011.638744

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  7 in total

1.  Retinal Pathologic Features on OCT among Eyes of Older Adults Judged Healthy by Color Fundus Photography.

Authors:  Jason N Crosson; Thomas A Swain; Mark E Clark; Carrie E Huisingh; Gerald McGwin; Cynthia Owsley; Christine A Curcio
Journal:  Ophthalmol Retina       Date:  2019-03-30

Review 2.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

3.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

4.  Fluorescence Lifetime Imaging Ophthalmoscopy: A Novel Way to Assess Macular Telangiectasia Type 2.

Authors:  Lydia Sauer; Rebekah H Gensure; Martin Hammer; Paul S Bernstein
Journal:  Ophthalmol Retina       Date:  2017-12-08

5.  FLUORESCENCE LIFETIME IMAGING OPHTHALMOSCOPY (FLIO) PATTERNS IN CLINICALLY UNAFFECTED CHILDREN OF MACULAR TELANGIECTASIA TYPE 2 (MACTEL) PATIENTS.

Authors:  Lydia Sauer; Alexandra S Vitale; Karl M Andersen; Barbara Hart; Paul S Bernstein
Journal:  Retina       Date:  2020-04       Impact factor: 3.975

6.  Macular telangiectasia type 2 accompanied by solitary retinal astrocytic hamartoma (case report).

Authors:  Martin Pencak; Jan Krasny; Miroslav Veith; Magdalena Vokrojova
Journal:  BMC Ophthalmol       Date:  2016-11-11       Impact factor: 2.209

7.  Comparing Fluorescence Lifetime Imaging Ophthalmoscopy in Atrophic Areas of Retinal Diseases.

Authors:  Lukas Goerdt; Lydia Sauer; Alexandra S Vitale; Natalie K Modersitzki; Monika Fleckenstein; Paul S Bernstein
Journal:  Transl Vis Sci Technol       Date:  2021-06-01       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.